From: Focused allergic rhinitis practice parameter for Canada
Clinical Practice Guidelines | Systematic Reviews | Randomized Controlled Trials | Other Original Studies of Interest |
---|---|---|---|
Brożek et al., 2017 [56] | Feng et al., 2021 [127] | Kim et al., 2018 [130] | Andhale et al., 2016 [122] |
Dykewicz et al., 2017 [4] | Krishnamoorthy et al., 2020 [131] | Okubo et al., 2017 [133] | Bhattachan et al., 2020 [123] |
Dykewicz et al., 2020 [5] | Velentza et al., 2020 [81] | Bian et al., 2021 [124] | |
Scadding et al., 2017 [40] | Wei, 2016 [83] | Dalgic et al., 2017 [125] | |
Wise et al., 2018 [50] | Xiao et al., 2016 [85] | Durham et al., 2016 [126] | |
Jindal et al., 2016 [128] | |||
Kaur et al., 2017 [129] | |||
Li et al., 2018 [132] | |||
Sansing-Foster et al., 2021 [135] | |||
Rajput et al., 2020 [134] | |||
Whalley et al., 2017 [136] | |||
Yoshihara et al., 2017 [137] | |||
Zhao et al., 2021 [138] | |||
Zuberi et al., 2020 [139] |